GGrantIndex
← Leaderboards

Brett D. Lindenbach

Rockefeller University

$10,442,003
Attributed
$13,067,295
Total exposure
8
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.4M · FY200522
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22

Funding mix

By agency

NIH$13,067,295 · 8

By mechanism

R01$11,843,231 · 5
K01$761,189 · 1
R21$457,875 · 1
R13$5,000 · 1

Top collaborators

Most similar at Rockefeller University

Same institution · by research overlap

Others in their field

Top investigators on “Genetic

Research focus

GeneticViralProteinsVirusHepatitis C VirusCellsMolecularAntiviral AgentsBiochemicalVirus ReplicationStructureRna VirusesInsightRna ReplicationComplexRna BindingInfectionNonstructural ProteinSiteLife Cycle StagesMapsVirionPublic Health RelevanceChronic Liver Disease

Grant awards (34)

Essential early events in the flavivirus lifecycle$418,750
R01 · FY2022 · AI · contact PI
Essential early events in the flavivirus lifecycle$418,750
R01 · FY2021 · AI · contact PI
Hepatitis C virus genome structure: dynamic roles in replication and infectivity$553,036
R01 · FY2020 · AI
Molecular determinants of hepatitis C virus assembly$418,750
R01 · FY2020 · AI · contact PI
Hepatitis C virus genome structure: dynamic roles in replication and infectivity$575,125
R01 · FY2019 · AI
Molecular determinants of hepatitis C virus assembly$418,750
R01 · FY2019 · AI · contact PI
Hepatitis C virus genome structure: dynamic roles in replication and infectivity$596,514
R01 · FY2018 · AI
Molecular determinants of hepatitis C virus assembly$418,750
R01 · FY2018 · AI · contact PI
Hepatitis C virus genome structure: dynamic roles in replication and infectivity$592,104
R01 · FY2017 · AI
Molecular determinants of hepatitis C virus assembly$418,750
R01 · FY2017 · AI · contact PI
The 24th International Symposium on Hepatitis C Virus and Related Viruses$5,000
R13 · FY2017 · AI · contact PI
Molecular determinants of hepatitis C virus assembly$418,126
R01 · FY2016 · AI · contact PI
Bacterial effectors as probes to study (+) RNA virus-host cell biology$208,125
R21 · FY2016 · AI · contact PI
Bacterial effectors as probes to study (+) RNA virus-host cell biology$249,750
R21 · FY2015 · AI · contact PI
Structure and function of the HCV replication complex$591,666
R01 · FY2014 · AI
Molecular determinants of hepatitis C virus assembly$409,613
R01 · FY2014 · AI · contact PI
Structure and function of the HCV replication complex$556,166
R01 · FY2013 · AI
Molecular determinants of hepatitis C virus assembly$385,036
R01 · FY2013 · AI · contact PI
Structure and function of the HCV replication complex$591,666
R01 · FY2012 · AI
Molecular determinants of hepatitis C virus assembly$409,613
R01 · FY2012 · AI · contact PI
Molecular determinants of hepatitis C virus infectivity$405,516
R01 · FY2012 · AI · contact PI
Structure and function of the HCV replication complex$591,890
R01 · FY2011 · AI
Molecular determinants of hepatitis C virus assembly$409,613
R01 · FY2011 · AI · contact PI
Molecular determinants of hepatitis C virus infectivity$405,516
R01 · FY2011 · AI · contact PI
Structure and function of the HCV replication complex$602,418
R01 · FY2010 · AI
Molecular determinants of hepatitis C virus assembly$413,750
R01 · FY2010 · AI · contact PI
Molecular determinants of hepatitis C virus infectivity$409,613
R01 · FY2010 · AI · contact PI
Molecular determinants of hepatitis C virus infectivity$413,750
R01 · FY2009 · AI · contact PI
Hepatocellular carcinoma: targeting HCV replication$162,378
K01 · FY2009 · CA · contact PI
Hepatocellular carcinoma: targeting HCV replication$162,378
K01 · FY2008 · CA · contact PI
Hepatocellular carcinoma: targeting HCV replication$162,378
K01 · FY2007 · CA · contact PI
Hepatocellular carcinoma: targeting HCV replication$126,168
K01 · FY2006 · CA · contact PI
Hepatocellular carcinoma: targeting HCV replication$36,210
K01 · FY2006 · CA · contact PI
Hepatocellular carcinoma: targeting HCV replication$111,677
K01 · FY2005 · CA